Excess Returns  cover image

Mike Green and Mike Taylor | PNL For a Purpose

Excess Returns

CHAPTER

Healthcare Innovation Portfolio Strategy and Focus on Sorepta Gene Therapy Company

Exploring the investment thesis behind Sarepta, a gene therapy company focused on Duchenne's muscular dystrophy treatment, and the strategic approach to healthcare innovation investments for asymmetric returns.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner